AbbVie Inc.
ABBV 263.96 (-0.48%) 1.26
EV: $544.30(B)
Total Equity: $-5.89(B)
Debt/Equity: 48
Dividend/share: $6.8
Div. yield: 2.59%
P/E: 74.56
Forward P/E: 18.84
P/FCF: 25.60
P/S: 7.25
P/B: N/A
EPS: $3.5
EPS (fwd): $14.0
FCF/share: $10.3
Revenue/share: $36.4
Book value/share: $-3.4
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Margins: Gross | Op. | Net
72.8% | 24.1% | 9.8%
0.0%of Portfolio
My holdings
Day change
Total change
Est. EPS Growth > 5%
5Y Shares Out Change < 0% ROIC > 10% Debt/Equity < 1 Current Ratio > 1 Quick Ratio > 1 Net Margin > 10% Past Net Income CAGR > 0%
TTM Financials
Income (TTM)
Revenue$64.39(B)
Gross profit$46.87(B)
EBITDA$30.76(B)
Net income$6.31(B)
Gross margin72.8%
Operating margin24.1%
Net margin9.8%
Shares outstanding1.77(B)
Balance sheet
Total assets$135.12(B)
Current assets$33.67(B)
Total liabilities$141.00(B)
Current liabilities$41.64(B)
Cash & Short-term inv.$6.57(B)
Long-term debt$62.53(B)
Total intangibles$84.66(B)
PP&E$5.80(B)
Cash flow (TTM)
FCF$18.21(B)
CapEx$-1.30(B)
Dividends paid$-11.98(B)
Stock issued$172.00(M)
Stock repurchased$-1.50(B)
Stock-based comp.$1.07(B)
Debt issued$7.73(B)
Debt repaid$-7.31(B)
Per share data (TTM)
Summary
ABBV Valuation & Price Targets
Favorite Valuation Methods
PEvaluation
—
Analyst targets
—
DCF (2-stage)
—
More Valuation Methods
DCF (simple)
—
DCF (exit mult.)
—
DDM
—
EPS growth
—
Revenue growth
—
Peter Lynch FV
—
Graham No.
—
PEvaluation
CURRENT PRICE
$264
23% Overvalued
BEAR
BASE
BULL
Fair P/E
Margin of safety
EPS
Market Model
Economic moat: Wide
EPS Estimates
| Low | Avg | High | # | |
| FY+1 | 13.9 | 14.0 | 14.1 | 26 |
| FY+2 | 15.1 | 16.3 | 17.6 | 24 |
| FY+3 | 16.5 | 18.0 | 20.0 | 19 |
| FY+4 | 17.6 | 19.8 | 22.0 | 13 |
| FY+5 | 17.8 | 20.6 | 22.3 | 13 |
Analyst Price Targets
CURRENT PRICE
$264
7% Undervalued
BEAR
BASE
BULL
Analyst Recommendations
2-stage DCF
First Stage Duration: 5 Years | |
| Starting Free Cash Flow | |
First Stage Growth Rate | |
Low Mid High | |
Terminal Growth Rate | |
Low Mid High | |
| Discount Rate | |
Discounted Cash Flow
Forecast years: 5 Years | |
Terminal Growth Rate | |
Low Mid High | |
| Discount Rate | |
Free cash flow estimates:
Discounted Cash Flow (exit mult.)
Forecast years: 5 Years | |
Exit FCF Multiple | |
Low Mid High | |
| Discount Rate | |
Free cash flow estimates:
Dividend Discount Model
| Annual Dividend | |
First Stage Length (Years): 0 Years | |
First Stage Growth Rate | |
Low Mid High | |
Final Growth Rate | |
Low Mid High | |
| Discount Rate | |
EPS Growth
Forecast years: 5 Years | |
| Starting EPS | |
EPS Growth Rate | |
Low Mid High | |
Final P/E | |
Low Mid High | |
| Discount Rate | |
Revenue Growth Valuation
Forecast Years: 10 Years | |
| Base Revenue | |
Revenue Growth Rate | |
Low Mid High | |
Final Net Margin | |
Low Mid High | |
Final P/E Ratio | |
Low Mid High | |
| Discount Rate | |
Peter Lynch Fair Value
| Earnings Per Share | |
Growth Rate | |
Low Mid High | |
Graham Formula
| Earnings Per Share | |
EPS Growth (7-10 years) | |
Low Mid High | |
| Government Bond Rate | |
Growth Estimates
Revenue
CAGR6.0%TTM
$64.39(B)
FY+1
23
5%
$67.59(B)
FY+2
22
9%
$73.49(B)
FY+3
19
8%
$79.09(B)
FY+4
13
6%
$83.92(B)
FY+5
13
2%
$86.02(B)
Net Income
CAGR41.7%TTM
$6.31(B)
FY+1
21
294%
$24.83(B)
FY+2
20
16%
$28.74(B)
FY+3
18
11%
$32.02(B)
FY+4
12
9%
$34.81(B)
FY+5
12
4%
$36.11(B)
EPS
CAGR42.2%TTM
$3.54
FY+1
26
296%
$14.01
FY+2
24
16%
$16.28
FY+3
19
11%
$18.03
FY+4
13
10%
$19.79
FY+5
13
4%
$20.57
FCF per share
CAGR15.5%TTM
$10.31
FY+1
4
32%
$13.60
FY+2
3
64%
$22.36
FY+3
3
7%
$20.80
FY+4
2
1%
$21.10
FY+5
2
0%
$21.15
Historical Financials (in USD)
Income
Revenue Operating Income Net IncomeCOGSGross ProfitTotal OpEx.R&DSG&AInterest ExpenseInterest IncomeOther Non-operating IncomePre-tax incomeIncome tax
Cash flow
Stock-based Comp. FCFCFONet IncomeD&AChange in Working CapitalCFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
Total Assets Total LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesShort-Term DebtAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data
EPS (Basic) FCF/Share Dividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios
P/E P/S EV/EarningsP/FCFP/BDebt/EquityPayout ratio
Margins
Net Income Margin Operating Margin Gross MarginEBITDA Margin
Returns
ROIC ROAROCEROE
Shares outstanding
Shares (Basic)Shares (Diluted)
Market Cap.
Market Cap.
KPIs
Operating Expense Breakdown
Research and Development Acquired In-Process R&D Selling, General, and Administrative Other Expenses
Revenue By Geography
United States International
Revenue By Segment
Neuroscience Immunology Women's Health Hematologic Oncology Aesthetics Other Products HCV Eye Care
ABBV vs Peers
Similar Companies
Ownership
Major holders
*Excludes indirect insider ownership
Insiders: 0.11%
Institutions: 77.36%
Other: 22.53%
Institutions: 77.36%
Other: 22.53%
Institutional ownership
Trading Summary
In the past year, insiders have sold a net of $18.92(M).
In the past year, Congress members have sold a net of $40501.
Based on the reported ranges: buys $4004–$60000, sells $20006–$125000.
Insider transactions
$0.002026-10$0.00
$0.002026-09$0.00
$8.18(M)2026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$5.60(M)2026-03$0.00
$5.15(M)2026-02$0.00
$0.002026-01$0.00
$0.002025-12$0.00
$0.002025-11$0.00
$0.002025-10$0.00
| Date | Shares | Total ($) | Price ($) | Name | Title | |
| Sell | 2026-08-14 | 32,710 | 8,177,500 | 250.0 | DONOGHOE NICHOLAS | Officer |
| Grant | 2026-08-14 | 32,710 | 2,584,744 | 79.0 | DONOGHOE NICHOLAS | Officer |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | FREYMAN THOMAS C | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | FALK THOMAS J | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | AUSTIN ROXANNE SCHUH | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | WADDELL FREDERICK H | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | RAPP EDWARD J | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | HART BRETT J | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | BURNSIDE WILLIAM H L | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | MEYER MELODY B | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | ROBERTS REBECCA B. | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | DAVIS JENNIFER L | Director |
| Grant | 2026-05-08 | 1,118 | 0 | 0.0 | QUAGGIN SUSAN E | Director |
| Sell | 2026-03-04 | 5,230 | 1,221,519 | 233.6 | PURDUE DAVID RYAN | Officer |
| Sell | 2026-03-02 | 18,668 | 4,375,549 | 234.4 | SIATIS PERRY C. | General Counsel |
| Sell | 2026-02-25 | 22,381 | 5,147,630 | 230.0 | SIATIS PERRY C. | General Counsel |
| Grant | 2026-02-25 | 22,381 | 3,863,458 | 172.6 | SIATIS PERRY C. | General Counsel |
| Grant | 2026-02-18 | 36,811 | 0 | 0.0 | SALEKI-GERHARDT AZITA | Chief Operating Officer |
| Grant | 2026-02-18 | 82,439 | 0 | 0.0 | MICHAEL ROBERT A. | Chief Executive Officer |
| Grant | 2026-02-18 | 53,749 | 0 | 0.0 | STEWART JEFFREY RYAN | Officer |
| Grant | 2026-02-18 | 29,057 | 0 | 0.0 | DONOGHOE NICHOLAS | Officer |
| Grant | 2026-02-18 | 48,838 | 0 | 0.0 | REENTS SCOTT T. | Chief Financial Officer |
| Grant | 2026-02-18 | 33,518 | 0 | 0.0 | SIATIS PERRY C. | General Counsel |
| Grant | 2026-02-18 | 18,137 | 0 | 0.0 | THAKKAR ROOPAL | Officer |
| Grant | 2026-02-18 | 6,071 | 0 | 0.0 | PURDUE DAVID RYAN | Officer |
| Grant | 2026-02-18 | 2,460 | 0 | 0.0 | CRUM DEMETRIS D | Officer |
Congressional trading
$0.002026-10$0.00
$0.002026-09$0.00
$0.002026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$325012026-01$8001
$160012025-12$0.00
$80012025-11$0.00
$80012025-10$24002
| Date | Politician | Party | Chamber | Amount ($) | |
| Sell | 2026-01-29 | Ro Khanna | D | House | $15,001 - $50,000 |
| Buy | 2026-01-23 | Ro Khanna | D | House | $1,001 - $15,000 |
| Sell | 2025-12-18 | Julie Johnson | D | House | $1,001 - $15,000 |
| Sell | 2025-12-08 | Julia Letlow | R | House | $1,001 - $15,000 |
| Sell | 2025-11-13 | Julie Johnson | D | House | $1,001 - $15,000 |
| Buy | 2025-10-30 | Lisa C. McClain | R | House | $1,001 - $15,000 |
| Buy | 2025-10-30 | Lisa C. McClain | R | House | $1,001 - $15,000 |
| Buy | 2025-10-30 | Lisa C. McClain | R | House | $1,001 - $15,000 |
| Sell | 2025-10-30 | Lisa C. McClain | R | House | $1,001 - $15,000 |
| Sell | 2025-08-22 | John Boozman | R | Senate | $1,001 - $15,000 |
Tools
Dividend Income
| Investment Amount | |
| Dividend Yield |
What is the Dividend Income Calculator?
The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.
How to Use This Calculator?
Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.
Required Investment
| Dividend Yield | |
| Desired Yearly Payout | |
| Desired Quarterly Payout | |
| Desired Monthly Payout |
What is the Required Investment Calculator?
The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.
How to Use This Calculator?
Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.
Future Dividend Yield
| Base Dividend | |
| Current Price | |
| Number of Years | |
| Dividend Growth Rate |
What is the Future Yield Calculator?
The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.
How to Use This Calculator?
Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.
Future Dividend Income
| Base Dividend | |
| Number of Years | |
| Dividend Growth Rate |
What is the Future Dividend Income Calculator?
The Future Dividend Income Calculator helps you estimate the future dividend income from your investments based on the current dividend yield and expected growth rate.
How to Use This Calculator?
Enter the current dividend yield, expected growth rate, and investment duration. Optionally, preload stock data to automatically fetch the dividend yield.